Weifeng Lai
The MOE Key Laboratory Of Cell Proliferation And Differentiation
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Scalable generation of T lymphocytes from human pluripotent stem cells in suspended organoids.
Journal: Stem cell reports
Published: February 17, 2026
Flow cytometry-guided ex vivo drug sensitivity testing informs venetoclax-based therapy in acute undifferentiated leukaemia.
Journal: British journal of haematology
Published: December 30, 2025
Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene.
Journal: Leukemia & lymphoma
Published: December 29, 2023
Targeted protein degradation reveals RNA Pol II heterogeneity and functional diversity.
Journal: Molecular cell
Published: March 03, 2022
Chemical reprogramming of human somatic cells to pluripotent stem cells.
Journal: Nature
Published: May 17, 2021
Human pluripotent stem cell-derived eosinophils reveal potent cytotoxicity against solid tumors.
Journal: Stem cell reports
Published: December 21, 2020
Chemically defined and xeno-free culture condition for human extended pluripotent stem cells.
Journal: Nature communications
Published: December 08, 2020
Targeting JNK pathway promotes human hematopoietic stem cell expansion.
Journal: Cell discovery
Published: August 21, 2018
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 23, 2017
Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency.
Journal: Cell
Published: December 20, 2016
Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State.
Journal: Cell stem cell
Published: April 05, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026